Sterically Hindered Iron Salen Complexes
(Asp), provided compelling evidence for the oxoiron(IV)
formation during oxygen activation.6 In addition, several
synthetic oxoiron(IV) species were successfully prepared
from biomimetic nonheme model complexes,7 which share
a redox-innocent nitrogen coordination motif together with
TauD. These epoch-making examples suggest that an non-
heme oxoiron(IV) species could possibly be stabilized by
the His coordination.
Another group of nonheme iron enzymes bear tyrosine
(Tyr) residues, which also play an important role in catalysis
in a more diverse manner due to a redox-noninnocent nature.8
For example, in the case of the ribonucleotide reductase R2
protein,9 the uncoordinated Tyr in close proximity to the
diiron(III) core is converted to the tyrosyl radical upon dioxy-
gen activation.10 A coordinated Tyr residue is also found
for mononuclear nonheme iron(III) enzymes such as proto-
catechuate 3,4-dioxygenase (3,4-PCD) bearing the His2Tyr2
coordination environment.11 Strikingly different from most
of the iron enzymes activating dioxygen on the iron center,
3,4-PCD is proposed to activate an iron-bound substrate for
reaction with dioxygen.12 A rather unique reaction sequence
of 3,4-PCD is possibly induced by the electronic effect
caused by the Tyr coordination to the iron(III) center.
Model studies concerning both coordinated and uncoor-
dinated Tyr in nonheme iron enzymes have been quite limited
so far.13-15 To examine the Tyr coordination to the iron(III)
center, Wieghardt et al. prepared a series of hexadentate iron
complexes containing a 1,4,7-triazacyclononane backbone
and three N-bound phenolate moieties.14 Stepwise one-
electron oxidation of their model complexes was reported
to result in three successive ligand-centered, phenolate-to-
phenoxyl radical conversions. Their phenoxyl radical com-
plexes are excellent models, which are stable at room
temperature. However, their model complexes do not neces-
sarily reproduce the biological system in all aspects, because
their model system does not have a vacant coordination site,
which is critical for accommodation of a biologically
important ligand such as H2O and OH. Indeed, 3,4-PCD has
a vacant coordination site, which is occupied with a solvent-
derived water molecule.11 The vacant coordination site on
the iron(III) center would be of considerable importance for
substrate-binding, considering the examples of the copper-
(II)-phenoxyl radical as a model for galactose oxidase
(GO).16 At present, reactivity of the iron(III)-phenoxyl
radical intermediates is not clear.14
In this context, we constructed a biologically more relevant
system based on a iron salen complex. A salen ligand well
reproduces the coordination environment by two His and two
Tyr. Most importantly, an iron salen complex has a vacant
fifth coordination site. Following the strategy utilized in the
heme enzyme model,17 we introduced bulky mesityl groups
to the salen framework to stabilize the monomeric iron center
and successfully prepared a H2O-coordinated iron salen
complex, which not only duplicates the structural features
around the iron(III) active site but also mimics the spectral
characteristics of 3,4-PCD.18 Herein, we carried out elec-
trochemical and chemical oxidation of the iron salen
complexes bearing Cl (1), OH2 (2), OEt (3), and OH (4) as
a fifth ligand (Figure 1). We also attempted mCPBA
(5) (a) Burger, R. M.; Kent, T. A.; Horwitz, S. B.; Mu¨nck, E.; Peisach, J.
J. Biol. Chem. 1983, 258, 1559-1564. (b) Burger, R. M.; Blanchard,
J. S.; Horwitz, S. B.; Peisach, J. J. Biol. Chem. 1985, 260, 15406-
15409. (c) Sam, J. W.; Tang, X.-J.; Peisach, J. J. Am. Chem. Soc.
1994, 116, 5250-5256. (d) Absalon, M. J.; Wu, W.; Kozarich, J. W.;
Stubbe, J. Biochemistry 1995, 34, 2076-2086. (e) Neese, F.; Zaleski,
J. M.; Zaleski, K. L.; Solomon, E. I. J. Am. Chem. Soc. 2000, 122,
11703-11724.
(6) (a) Price, J. C.; Barr, E. W.; Tirupati, B.; Bollinger, J. M., Jr.; Krebs,
C. Biochemistry 2003, 42, 7497-7508. (b) Proshlyakov, D. A.;
Henshaw, T. F.; Monterosso, G. R.; Ryle, M. J.; Hausinger, R. P. J.
Am. Chem. Soc. 2004, 126, 1022-1023. (c) Riggs-Gelasco, P. J.; Price,
J. C.; Guyer, R. B.; Brehm, J. H.; Barr, E. W.; Bollinger, J. M., Jr.;
Krebs, C. J. Am. Chem. Soc. 2004, 126, 8108-8109.
(7) (a) Grapperhaus, C. A.; Mienert, B.; Bill, E.; Weyhermu¨ller, T.;
Wieghardt, K. Inorg. Chem. 2000, 39, 5306-5317. (b) Rohde, J.-U.;
In, J.-H.; Lim, M. H.; Brennessel, W. W.; Bukowski, M. R.; Stubna,
A.; Mu¨nck, E.; Nam, W.; Que, L., Jr. Science 2003, 299, 1037-1039.
(c) Lim, M. H.; Rohde, J.-U.; Stubna, A.; Bukowski, M. R.; Costas,
M.; Ho, R. Y. N.; Mu¨nck, E.; Nam, W.; Que, L., Jr. Proc. Natl. Acad.
Sci. U.S.A. 2003, 100, 3665-3670. (d) Balland, V.; Charlot, M.-F.;
Banse, F.; Girerd, J.-J.; Mattioli, T. A.; Bill, E.; Bartoli, J.-F.; Battioni,
P.; Mansuy, D. Eur. J. Inorg. Chem. 2004, 301-308. (e) Kaizer, J.;
Klinker, E. J.; Oh, N. Y.; Rohde, J.-U.; Song, W. J.; Stubna, A.; Kim,
J.; Mu¨nck, E.; Nam, W.; Que, L., Jr. J. Am. Chem. Soc. 2004, 126,
472-473. (f) Decker, A.; Rohde, J.-U.; Que, L., Jr.; Solomon, E. I. J.
Am. Chem. Soc. 2004, 126, 5378-5379. (g) Rohde, J.-U.; Torelli, S.;
Shan, X.; Lim, M. H.; Klinker, E. J.; Kaizer, J.; Chen, K.; Nam, W.;
Que, L., Jr. J. Am. Chem. Soc. 2004, 126, 16750-16761. (h) Ghosh,
A.; Tiago de Oliveira, F. Yano, T.; Nishioka, T.; Beach, E. S.;
Kinoshita, I.; Mu¨nck, E.; Ryabov, A. D.; Horwitz, C. P.; Collins T. J.
J. Am. Chem. Soc. 2005, 127, 2505-2513. (g) Kim, S. O.; Sastri, C.
V.; Seo, M. S.; Kim, J.; Nam, W. J. Am. Chem. Soc. 2005, 127, 4178-
4179.
(13) Chaudhuri, P.; Wieghardt, K. Prog. Inorg. Chem. 2001, 50, 151-
216.
(14) (a) Hockertz, J.; Steenken, S.; Wieghardt, K.; Hildebrandt, P. J. Am.
Chem. Soc. 1993, 115, 11222-11230. (b) Adam, B.; Bill, E.; Bothe,
E.; Goerdt, B.; Haselhorst, G.; Hildenbrand, K.; Sokolowski, A.;
Steenken, S.; Weyhermu¨ller, T.; Wieghardt, K. Chem.sEur. J. 1997,
3, 308-319. (c) Snodin, M. D.; Ould-Moussa, L.; Wallmann, U.;
Lecomte, S.; Bachler, V.; Bill, E.; Hummel, H.; Weyhermu¨ller, T.;
Hildebrandt, P.; Wieghardt, K. Chem.sEur. J. 1999, 5, 2554-2565.
(15) (a) Goldberg, D. P.; Watton, S. P.; Masschelein, A.; Wimmer, L.;
Lippard, S. J. J. Am. Chem. Soc. 1993, 115, 5346-5347. (b) Goldberg,
D. P.; Koulougliotis, D.; Brudvig, G. W.; Lippard, S. J. J. Am. Chem.
Soc. 1995, 117, 3134-3144.
(16) (a) Wang, Y.; Stack, T. D. P. J. Am. Chem. Soc. 1996, 118, 13097-
13098. (b) Halfen, J. A.; Jazdzewski, B. A.; Mahapatra, S.; Berreau,
L. M.; Wilkinson, E. C.; Que, L., Jr.; Tolman, W. B. J. Am. Chem.
Soc. 1997, 119, 8217-8227. (c) Wang, Y.; DuBois, J. L.; Hedman,
B.; Hodgson, K. O.; Stack, T. D. P. Science 1998, 279, 537-540. (d)
Itoh, S.; Taki, M.; Takayama, S.; Nagatomo, S.; Kitagawa, T.;
Sakurada, N.; Arakawa, R.; Fukuzumi, S. Angew. Chem., Int. Ed. 1999,
38, 2774-2776. (e) Chaudhuri, P.; Hess, M.; Mu¨ller, J.; Hildenbrand,
K.; Bill, E.; Weyhermu¨ller, T.; Wieghardt, K. J. Am. Chem. Soc. 1999,
121, 9599-9610. (f) Thomas, F.; Gellon, G.; Gautier-Luneau, I.; Saint-
Aman, E.; Pierre, J.-L. Angew. Chem., Int. Ed. 2002, 41, 3047-3050.
(17) (a) Groves, J. T.; Haushalter, R. C.; Nakamura M.; Nemo, T. E.; Evans,
B. J. J. Am. Chem. Soc. 1981, 103, 2884-2886. (b) Balch, A. L.;
Latos-Grazynski, L.; Renner, M. W. J. Am. Chem. Soc. 1985, 107,
2983-2985. (c) Sugimoto, H.; Tung, H.-C.; Sawyer, D. T. J. Am.
Chem. Soc. 1988, 110, 2465-2470. (d) Fujii, H. J. Am. Chem. Soc.
1993, 115, 4641-4648.
(8) Solomon, E. I.; Brunold, T. C.; Davis, M. I.; Kemsley, J. N.; Lee,
S.-K.; Lehnert, N.; Neese, F.; Skulan, A. J.; Yang, Y.-S.; Zhou, J.
Chem. ReV. 2000, 100, 235-349.
(9) Nordlund, P.; Sjo¨berg, B.-M.; Eklund, H. Nature 1990, 345, 593-
598.
(10) Stubbe, J.; Donk, W. A. v. d. Chem. ReV. 1998, 98, 705-762.
(11) (a) Ohlendorf, D. H.; Lipscomb, J. D.; Weber, P. C. Nature 1988,
336, 403-405. (b) Ohlendorf, D. H.; Orville, A. M.; Lipscomb, J. D.
J. Mol. Biol. 1994, 244, 586-608.
(12) Costas, M.; Mehn, M. P.; Jensen, M. P.; Que, L., Jr. Chem. ReV. 2004,
104, 939-986.
(18) Fujii, H.; Funahashi, Y. Angew. Chem., Int. Ed. 2002, 41, 3638-
3641.
Inorganic Chemistry, Vol. 44, No. 22, 2005 8157